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Abstract
Kv4 pore-forming subunits co-assemble with β-subunits including KChIP2 and 
DPP6 and the resultant complexes conduct cardiac transient outward K+ current (Ito). 
Compound NS5806 has been shown to potentate Ito in canine cardiomyocytes; how-
ever, its effects on Ito in other species yet to be determined. We found that NS5806 
inhibited native Ito in a concentration-dependent manner (0.1~30 μM) in both mouse 
ventricular cardiomyocytes and human-induced pluripotent stem cell-derived car-
diomyocytes (hiPSC-CMs), but potentiated Ito in the canine cardiomyocytes. In 
HEK293 cells co-transfected with cloned Kv4.3 (or Kv4.2) and β-subunit KChIP2, 
NS5806 significantly increased the peak current amplitude and slowed the inactiva-
tion. In contrast, NS5806 suppressed the current and accelerated inactivation of the 
channels when cells were co-transfected with Kv4.3 (or Kv4.2), KChIP2 and another 
β-subunit, DPP6-L (long isoform). Western blot analysis showed that DPP6-L was 
dominantly expressed in both mouse ventricular myocardium and hiPSC-CMs, while 
it was almost undetectable in canine ventricular myocardium. In addition, low level 
of DPP6-S expression was found in canine heart, whereas levels of KChIP2 expres-
sion were comparable among all three species. siRNA knockdown of DPP6 antago-
nized the Ito inhibition by NS5806 in hiPSC-CMs. Molecular docking simulation 
suggested that DPP6-L may associate with KChIP2 subunits. Mutations of putative 
KChIP2-interacting residues of DPP6-L reversed the inhibitory effect of NS5806 
into potentiation of the current. We conclude that a pharmacological modulator can 
elicit opposite regulatory effects on Kv4 channel complex among different species, 
depending on the presence of distinct β-subunits. These findings provide novel in-
sight into the molecular design and regulation of cardiac Ito. Since Ito is a potential 
therapeutic target for treatment of multiple cardiovascular diseases, our data will 
facilitate the development of new therapeutic Ito modulators.
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1 |  INTRODUCTION
Kv4 channels are the primary subunits of the rapidly activat-
ing and inactivating K+ channels, contributing to the cardiac 
transient outward K+ currents (Ito).1 Due to its unique ki-
netic features, Kv4 channels play a central role in controlling 
cardiac excitation and shaping the cardiac action potentials 
(AP). The reduction of the Ito density and the consequent 
prolongation of the action potential duration is a consistent 
finding in many pathological conditions such as cardiac hy-
pertrophy and heart failure (HF) and may contribute to the ar-
rhythmias.2,3 Hence, the pharmacological Ito activation may 
have therapeutic value in HF.
It is generally accepted that there are two Ito components 
with distinct recovery kinetics: the fast (Ito,f) and slow (Ito,s).4 
The Kv4.2 (KCND2) and Kv4.3 (KCND3) conduct Ito,f, while 
Kv1.4 (KCNA4) forms Ito,s channels. In human and canine 
ventricular myocytes, functional Ito,f channels are likely to be 
assembled from Kv4.3 homotetramers because Kv4.2 is not 
expressed.5,6 In mice, Kv4.2 is believed to be the principal 
α-subunit of Ito,f.7 Auxiliary subunits, such as K+ channel-in-
teracting proteins (KChIPs) or dipeptidyl peptidase-like pro-
teins (DPPs), are known to interact with and modulate the 
properties of Kv4 channels.8,9 Within these, KChIP2 and 
DPP6 have been proposed as most likely candidates that 
co-assemble with Kv4 subunits in the human heart.9 KChIP2 
is a cytosolic Ca2+-binding auxiliary subunit that interacts 
with the amino terminus of the Kv4 α-subunit; it facilitates 
channel trafficking, slows the Kv4 current inactivation ki-
netics, accelerates the recovery from inactivation, and shifts 
the voltage dependence of steady-state inactivation to more 
positive potentials.10 DPP6 is a single-membrane-spanning 
protein that accelerates current inactivation and recovery 
kinetics and shifts both activation and inactivation voltage 
dependencies of Kv4 channels to more negative potentials.11 
Co-expression of Kv4.3 with KChIP2 and DPP6 in heterolo-
gous systems results in currents with kinetics similar to those 
of the Ito in human ventricular myocytes.9 Thus, Kv4-KChIP-
DPP complex could be a valuable target for therapeutic ap-
proaches to cardiac diseases.
A small molecule sulfonylurea compound, NS5806, has 
been found to potentate Ito in canine cardiac myocytes by 
slowing the current inactivation. Further studies have shown 
that current potentiation by NS5806 depends on the presence 
of KChIPs in the recombinant Kv4 channel complex.12,13 
NS5806 was shown to reverse the HF-associated reduction 
of Ito density in canine ventricular cardiomyocytes14,15 and, 
thus, NS5806 was put forward as a prototypic Ito opener and 
a candidate template for antiarrhythmic drugs.16 However, its 
effects on Ito in other species yet to be determined. Given 
its proposed therapeutic value, a better understanding of the 
molecular mechanisms underlying the modulation of Kv4 
channels by NS5806 is urgently required.
Ito is the major component of the cardiac AP repolariza-
tion in rodents and the mice have become an important model 
for the molecular studies of Ito. In addition, human-induced 
pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) 
have recently become another important system for modeling 
human cardiac disease and drug screening.17 In this study, we 
examined the effect of NS5806 on Ito in native mouse ventric-
ular cardiomyocytes and in the hiPSC-CMs. Unexpectedly, 
we discovered that in contrast to its effect in canine cardio-
myocytes, NS5806 decreased the amplitude of native Ito in 
both cell types with a significant acceleration of the current 
inactivation. We used primary cardiac cells from different 
species, hiPSC-CMs, expression system, and modeling to 
probe the intricate molecular mechanisms underlying the 
species-specific differences in pharmacological responses of 
Ito to NS5806.
2 |  MATERIALS AND METHODS
2.1 | Animals
Male C57BL/6 mice (weight 20-25 g, 7- to 8-week old) and 
male Beagle dogs (weight 6-8 Kg, 1- to 2-year old) were pur-
chased from the Vital River Laboratory Animal Technology 
Company (Beijing, China). Animal care standards and all 
experimental procedures were approved by the Animal 
Care and Ethical Committee of Hebei Medical University 
(Shijiazhuang, China). Mice were housed under the specific 
pathogen-free (SPF) conditions with five mice per cage and 
dogs were raised in a conventional animal room. All ani-
mals were kept under controlled environmental conditions 
(12  hours light/12  hours dark cycle, room temperature 21-
23°C and humidity 50%-60%) with free access to standard 
laboratory food pellets and water.
2.2 | Ventricular cardiomyocytes isolation
Single ventricular myocytes were enzymatically isolated 
from five mouse and three canine hearts as described pre-
viously.18,19 Briefly, animals were injected with heparin 
(1.0  U·kg−1) and anaesthetized with sodium pentobarbital 
K E Y W O R D S
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(35 mg·kg−1). Hearts were rapidly removed, and a wedge 
from canine left ventricular free wall supplied by a descend-
ing branch of the circumflex artery was excised. Intact mouse 
heart or wedge preparation from canine heart were mounted 
on a Langendorff apparatus (Radnoti Inc, Monrovia, CA, 
USA), and retrogradely perfused through the aorta with Ca2+-
free Tyrode's solution (mM): NaCl 140, KCl 5.4, MgCl2 
1, HEPES 10, and glucose 10 (pH 7.4 with NaOH). After 
5 minutes of perfusion, the same solution supplemented with 
Type II collagenase (Worthington Biochemical Corporation, 
Lakewood, NJ, USA; 0.4 mg·mL−1) was applied for 
10-15 minutes. Once ventricular tissue was softened, hearts 
were removed from the apparatus. The left apex ventricles of 
mouse heart or canine epicardium ventricles were sliced into 
small pieces and incubated in KB solution (in mM): KOH 80, 
KCl 40, KH2PO4 25, MgSO4 3, Glutamic acid 50, Taurine 
20, HEPES 10, EGTA 1, and Glucose 10 (pH 7.4 adjusted 
with KOH). Cells were then harvested and were used for 
patch-clamp recordings within 4-6 hours after isolation.
2.3 | In vitro electrocardiographic 
(ECG) recordings
The Langendorff hearts from five mice were prepared with 
the above method and were retrogradely perfused (2-2.5 
ml·min−1; 37  ±  0.5°C) through the aorta with oxygenated 
Tyrode's solution (in mM): NaCl 140, KCl 5.4, MgCl2 1, 
CaCl2 2, HEPES 10, and glucose 10 (pH 7.4 adjusted with 
NaOH) using peristaltic pump. The hearts were put in the 
thermostatic chamber and allowed to equilibrate for a mini-
mum of 30  minutes to ensure the stable ECG recordings 
before drug testing. The in vitro equivalent lead II ECG 
waveforms were recorded by the Biopac 150 System (Biopac 
Systems, USA) at 5  kHz. The QT interval was defined as 
the time between the first deviation from the isoelectric line 
during the PQ interval until the end of the T wave, and was 
averaged from 30 consecutive beats between 5 and 10 min-
utes after the presence of test compound. The heart rate was 
defined by RR intervals. The heart rate–corrected QT inter-
vals (QTc) were calculated according to a parabolic equation 
QT = (333/RR)0.601.20
2.4 | cDNA constructs and mutagenesis
cDNAs coding for human Kv4.3 (NM_172198), Kv4.2 
(NM_012281), KChIP2 (NM_173192), DPP6-L (long iso-
form; NM_130797), and DPP6-S (short isoform; NM_001936) 
were cloned into pcDNA3.1 by Youbio (Changsha, China). 
Alanine substitution at positions R7, P33, D36, G38, L44 in 
DPP6-L was performed by Youbio. Validity of all cDNA 
constructs was confirmed by sequencing.
2.5 | Cell culture, transfection, and 
siRNA treatment
Human embryonic kidney (HEK) 293 cells were cultured 
in Dulbecco’s modified Eagle’s medium (DMEM, Gibco) 
supplemented with 10% fetal calf serum (Gibco) with 5% 
CO2 at 37°C. The HEK293 cells were transiently co-trans-
fected with Kv4.3 (or Kv4.2), KChIP2, and DPP6 plasmid 
using Lipofectamine 2000 (Invitrogen) according to the 
manufacturer’s instructions. The green fluorescent protein 
(GFP) was used as a reporter. The human-induced pluri-
potent stem cell-derived cardiomyocytes (hiPSC-CMs, 
50-60  days of maturity; Cellapybio, Beijing, China) were 
maintained in serum-free medium (Cellapybio) on 24-well 
dishes coated with Matrigel Matrix (BD-Biocoat, Corning, 
USA) with 5% CO2 at 37°C. The small interfering RNA 
(siRNA) duplex against the human DPP6 gene (NM_130797, 
5′-GGTCCATCATCGGCTCTTT-3′) was designed and con-
structed by Ribobio (Guangdong, China). hiPSC-CMs were 
transfected with siRNA using Lipofectamine RNAiMax 
(Invitrogen) according to the manufacturer’s instruction at 
a final siRNA concentration of 100  nM. A non-matching 
siRNA was used as a negative control. Cells were used for 
experiments 48 hours after transfection.
2.6 | Patch-clamp recordings
The conventional whole-cell patch-clamp recordings were 
performed at room temperature (22-25°C) using an EPC-
10 amplifier in combination with Patchmaster software 
(V2x73.2, HEKA, Lambrecht, Germany) and data analysis 
was performed using Origin 8.6 software (Wavemetrics, 
Microcal, USA). The access resistance was typically 
within 5  MΩ. Whole-cell membrane capacitances were 
cancelled and series resistance compensated by 80%. For 
native Ito recording, the external solution contained (in 
mM) N-methyl-d-glucamine (NMG) 130, KCl 5, MgCl2 1, 
CaCl2 1, HEPES 10, and glucose 10 (pH 7.4 with HCl) 
and the pipette solution contained (in mM) KCl 140, Mg-
ATP 4, MgCl2 1, EGTA 10, and HEPES 10 (pH 7.4 with 
KOH). The CdCl2 (300 nM) was added in the bath solu-
tion to block voltage-gated Ca2+ channels. For recording 
from HEK293 cells, the extracellular solution contained (in 
mM) NaCl 140, KCl 5, CaCl2 1.8, MgCl2 1.2, HEPES 10, 
and Glucose 10 (pH 7.4 with NaOH) and the patch pipette 
solution contained (in mM) KCl 140, Mg-ATP 4, MgCl2 1, 
EGTA 10, and HEPES 10 (pH 7.4 with KOH). To isolate 
distinct K+ current components, a rapidly activating and 
inactivating current, Ito,f; a rapidly activating but slowly 
inactivating current, Ik,slow; and a slowly activating non-
inactivating current, Iss, the decay phases of the currents 
evoked during long (4.5  seconds) depolarizing voltage 
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steps to various test potentials were fitted by the sum of 
two exponents. The following equation was used: y(t) = A
1·exp(−t/τ1) + A2·exp(−t/τ2) + Ass., where t is time, τ1 and 
τ2 are, respectively, the time constants of decay of Ito,f and 
Ik,slow; A1 and A2 are, respectively, the amplitudes of Ito,f 
and Ik,slow, and Ass is the amplitude of Iss.21
2.7 | Western blot and 
immunoprecipitation assays
Immunoblots were performed as previously described.22 
Proteins were prepared from the left ventricular free 
wall of five mouse hearts, epicardial tissue of three dog 
hearts, and three batches of hiPSC-CMs (50-60  days of 
maturity). Protein concentration was measured by BCA 
protein assay (Pierce, USA). Denatured samples (60  μg/
lane) were separated on precast 10% SDS-PAGE gels and 
transferred to PVDF membranes. Quantification of the sig-
nals was performed by Odyssey Infrared Imaging System 
(LICOR 9120, Li-COR, Lincoln, NE, USA). Densitometry 
was used for quantification; the protein band pixel intensi-
ties were normalized to the GAPDH band in each sample. 
The values were then averaged from all the different sets 
of experiments. The following primary antibodies were 
used: anti-DPP6 (a polyclonal antibody raised in rabbit 
against a purified peptide corresponding to amino acid resi-
dues 400-550 of human DPP6, Abcam, UK); anti-Kv1.4 
(a polyclonal antibody raised in rabbit against a purified 
peptide corresponding to amino acid residues 589-655 of 
rat Kv1.4 located in intracellular C-terminus); anti-Kv4.3 
(a polyclonal antibody raised in rabbit against a purified 
peptide corresponding to amino acid residues 451-468 of 
human Kv4.3 located in intracellular C-terminus); anti-
KChIP2 (a polyclonal antibody raised in rabbit against a 
purified peptide corresponding to amino acid residues 2-15 
of human KChIP2 located in intracellular N-terminus) 
(Alomone Labs, Israel); and anti-GAPDH (Proteintech, 
Wuhan, China).
2.8 | RT-PCR
Total RNA from hiPSC-CMs was extracted using 
Trizol Reagent (Takara, Japan). cDNA was synthe-
sized using the PrimeScript RT Reagent Kit (Takara, 
Japan). Real-time PCR was performed using ABI 
Prism 7300 Real-Time PCR System (ABI, Wilmington, 
USA). The following primers (synthesized by Sangon 
Biotech, Shanghai, China) were used: GAPDH forward: 
5′-AAGACCTTGGGCTGGGACT-3′; GAPDH reverse: 
5′-CCAAATCCGTTGACTCCGAC3′. DPP6 forward: 
5′-AAAGAGAGAAAGCACAGCCAGAG-3′; DPP6 
reverse: 5′-CTTCTGGTGGGTCCAGACTTT-3′. The am-
plification curves to provide Ct values were normalized 
to the reference gene GAPDH; the changes in expression 
were calculated using the 2−ΔΔCT method.
2.9 | Computational prediction of 
interaction between KChIP2 and DPP6
Computer simulations and analyses were performed 
by Beijing Abace Biotechnology Co., Ltd. BLAST and 
HHBlist were used with default parameters to identify evo-
lutionary related structures matching the KChIP2 sequence 
(UniProtKB accession number Q9NS61). Kv channel-in-
teracting protein 4 (KChIP4a; PDB ID: 3DD4) was identi-
fied as the highest ranked homolog. A known structure of 
KChIP4a,23 which had 80% sequence identity with KChIP2, 
was thus used as a template to generate a homology model 
of KChIP2. No appropriate templates were identified for 
DPP6-L in the Protein Data Bank. Therefore, ab initio 
protein prediction approaches were employed for struc-
ture modeling of DPP6-Lin. The docking experiment was 
performed using the program GRAMM. A global search 
on the surface of KChIP2 was done to identify potential 
binding sites for DPP6-Lin. All the predicted binding po-
sitions were ranked based on their docking scores. As a 
result, DPP6-Lin was successfully docked into KChIP2 
and a total of 10 models were generated. The interactions 
between DPP6-L and KChIP2 were analyzed using the 
PDBePISA web server.
2.10 | Chemicals
NS5806 (Tocris, UK) was prepared as a 20  mM stock so-
lution in DMSO and stored in −20°C. The highest final 
concentration of DMSO in external solution was ≤0.1%, a 
concentration that had no effect on the current recording. 
Phrixotoxin-2 (Abcam, UK) was prepared as a 1 mM stock 
solution in water and stored at −20°C. Other common chemi-
cals were from Sigma.
2.11 | Data and statistical analysis
All data are presented as Mean ± SEM. Data analysis and sta-
tistics were carried out using Origin 8.6 software (OriginLab 
Corporation, USA). Group comparisons were performed 
with paired Student’s t tests (for comparisons before and after 
drug treatment) and unpaired Student’s t tests (for two-group 
comparisons) and ANOVA with Dunnett’s post hoc tests 
(for multiple-group comparisons). The “n” and “N” were 
used to represent the number of cells and animals/samples, 
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respectively. Post hoc tests were only performed when F 
achieved P < .05 and there was no significant variance in the 
homogeneity. The differences were considered significant at 
P < .05.
3 |  RESULTS
3.1 | Effect of NS5806 on outward 
potassium current in mouse left ventricular 
myocytes
We first tested the effect of NS5806 (Figure 1A, inset) on the 
outward potassium currents in mouse ventricular myocytes. 
The currents were recorded using a series of long (4.5 sec-
onds) depolarizing voltage steps from −40 to +60 mV from 
a holding potential of −80  mV. NS5806 significantly sup-
pressed the outward potassium currents; the peak current 
density was significantly decreased at all potentials positive 
to −10 mV (Figure 1A,B). The inhibition was concentration-
dependent (Figure 1C). Current inactivation was well fitted 
with a double-exponential equation providing rapid and slow 
inactivation time constants, τ1 and τ2, respectively.21 NS5806 
induced significant acceleration of the current inactivation; at 
+60 mV τ1 changed from the control value of 53.8 ± 5.5 to 
41.8 ± 3.0 ms and τ2 from 1279.8 ± 60.3 to 906.3 ± 53.7 ms 
(Figure 1D). The effect of NS5806 on cardiac electrophysio-
logical activity was further tested in isolated perfused mouse 
hearts. Representative in vitro ECG waves in the presence of 
NS5806 at different concentrations are shown in Figure 1E. 
Analysis of ECG recordings revealed that NS5806 signifi-
cantly prolonged the heart rate–corrected QT interval (QTc) 
in a concentration-dependent manner (Figure 1F). These re-
sults indicated that NS5806 suppressed repolarizing currents 
and thus prolonged QT interval in mouse heart.
The outward potassium currents in adult mouse myocytes 
from free left ventricular wall has three distinct components: 
a rapidly activating and inactivating, Ito,f; a rapidly activating 
but slowly inactivating current, Ik,slow; and a slowly activating 
non-inactivating current, Iss.21 To isolate these components, 
we used two-exponent fit of current inactivation (see above 
and Methods) and selective pharmacology. Phrixotoxin-2, a 
specific Kv4 channel blocker,24 selectively blocked the Ito,f 
in mouse ventricular cardiomyocytes in a concentration-de-
pendent manner; at 1  μM Phrixotoxin-2 almost completely 
suppressed Ito,f (Figure S1). Interestingly, after the applica-
tion of 30 μM NS5806, 1 μM Phrixotoxin-2 failed to inhibit 
remaining K+ current, suggesting that NS5806 suppressed 
the majority of Kv4-dependent fraction of Ito,f (Figure 2A). 
Further analysis revealed that NS5806 decreased the current 
amplitude of both Ito,f and Ik,slow in a concentration-depen-
dent manner, but it did not affect Iss (Figure 2B). The IC50 
values for the inhibition of Ito,f and Ik,slow were 12.5 ± 0.2 and 
2.7 ± 0.7 μM, respectively. We then used shorter (500 ms) 
depolarizing pulses (Figure 2C), as under such conditions 
the peak current amplitude (with the sustained component 
subtracted) was shown to represent “pure” Ito,f.25 Figure 2C 
shows representative current traces before and after the appli-
cation of 10 μM NS5806 (top panel), as well as the NS5806-
sensitive current fraction (bottom panel). The inactivation 
phase of the NS5806-sensitive current fraction was well fitted 
by a single exponential equation, which gave time constants 
within the same range as τ1 provided by double-exponential 
fitting under long depolarization pulse (data not shown). 
Under these conditions, NS5806 inhibited Ito,f, with the IC50 
of 10.9 ± 0.5 μM (Figure 2D; cf. to IC50 of 12.5 ± 0.2 μM 
obtained from long depolarization pulse recordings). These 
data confirmed that NS5806 suppressed Ito,f in mouse cardio-
myocytes. Ik,slow was also inhibited but Iss was not affected.
The effect of NS5806 on the steady-state inactivation of 
Ito,f was then examined under the voltage protocol shown in 
the inset in Figure 2E. The inactivation phases of the currents 
evoked at +60 mV after each pre-pulse potential were fitted 
by double-exponential equation to quantify the effect on Ito,f. 
NS5806 induced significant leftward shift of the voltage de-
pendence of steady-state inactivation with the half-maximal 
voltage (V1/2) shifted from −20.9 ± 0.7 mV under control con-
ditions to −34.5 ± 0.8 mV in the presence of the drug. The 
recovery from inactivation of Ito,f was evaluated by a paired-
pulse voltage clamp protocol (Figure 2F, inset). The first in-
activating pulse to +60  mV (4.5  seconds) was followed by 
variable repolarization periods (0-2000 ms), with subsequent 
second pulse to +60 mV. The amplitudes of Ito,f were obtained 
by two-exponential fitting and then normalized to their re-
spective maximal current amplitudes. The recovery from inac-
tivation was well fitted by single-exponential equation (Figure 
2F); NS5806 significantly accelerated the recovery with the 
time constant changing from 24.5 ± 1.3 to 11.6 ± 1.0 ms.
3.2 | Effect of NS5806 on Ito in hiPSC-CMs
To identify whether the inhibitory effect of NS5806 on Kv4 
channels was just limited to rodents, we investigated the 
effect of NS5806 on Ito in hiPSC-CMs. The molecular cor-
relates of Ito channel were first assessed using western blot 
(Figure 3A,B), which revealed that Kv4.3 was the domi-
nant subunit and Kv1.4 was almost undetectable. However, 
we found that there were comparable expression levels of 
Kv1.4 in mouse and canine heart (Figure S2). Similar to 
murine cardiomyocytes, NS5806 induced prominent inhibi-
tory effect in hiPSC-CMs. Representative Ito traces before 
and after NS5806 are shown in Figure 3C. The amplitude 
of Ito (peak minus steady-state current) was significantly in-
hibited by 10 μM NS5806, with a decrease of 64.6 ± 5.9% 
from 21.9 ± 1.5 pA/pF (control) to 7.6 ± 1.2 pA/pF in the 
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presence of the drug (measured at +60  mV; Figure 3C). 
The effect was concentration-dependent with an IC50 of 
8.3  ±  1.9  μM (Figure 3E). The current inactivation phase 
was best fit with a single exponential equation; the Ito inac-
tivation kinetics was significantly accelerated over a voltage 
range from +10 to +60 mV, as reflected by the decrease of τ 
F I G U R E  1  Effects of NS5806 on the outward potassium currents in mouse left ventricular myocytes. A, Representative currents recorded in 
the absence (left) and presence of 10 μM NS5806 (right) using voltage protocol depicted in the inset. The molecular structure of NS5805 is shown 
in the upper inset. B, I–V relationships of the peak outward current (expressed as current density) before and after the application of 10 μM NS5806 
(n = 25, N = 5, **P < .01, ***P < .001 vs Control). C, Concentration dependence of the effect of NS5806 on outward potassium currents; the 
IC50 = 6.6 μM. The number under each dataset represents the number of cardiomyocytes (from five hearts) tested at each concentration. D, Effect 
of NS5806 on the voltage dependence of inactivation. The inactivation phases of outward potassium current at +60 mV were fitted by double-
exponential function to provide the fast (τ1) and slow (τ2) time constants (n = 25, N = 5, *P < .05, **P < .01 vs Control). E, Representative ECG 
waveforms from Lengendorff perfused mouse hearts at different concentrations of NS5806 (left). The arrows indicate the representative ECG 
waveforms enlarged from the boxed area of each corresponding trace. F, Histogram of Mean (± SEM) QTc intervals from recordings as in E 
(N = 5, *P < .05, **P < .01, ***P < .001 vs Control) 
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values from 45.8 ± 3.5 to 32.6 ± 2.0 ms at +60 mV (Figure 
3F). The steady-state inactivation curves were also ana-
lyzed. Consistently, NS5806 shifted the V1/2 toward negative 
potentials (from −24.9 ± 0.4 to −38.5 ± 0.3 mV; Figure 3G). 
However, NS5806 did not significantly affect the recovery 
from inactivation of Ito (Figure 3H). These results indicated 
F I G U R E  2  Effects of NS5806 on different K+ current components in mouse left ventricular myocytes. A, Time course of response of 
outward K+ current to Phrixotoxin-2 (1 μM) in the presence of NS5806 (30 μM). B, Concentration-dependent effect of NS5806 on the three 
components of K+ current: Ito,f, Ik,slow, and Iss (see Methods). C, Representative outward potassium currents were recorded in the absence (grey) 
and presence (black) of 10 μM NS5806. Currents were evoked by 500 ms square voltage steps (inset); corresponding NS5806-sensitive currents 
(bottom) were acquired through digital subtraction. D, Concentration-dependent effect of NS5806 on Ito,f recorded under the pulse protocol shown 
in C; n = 15, N = 5. E, Steady-state inactivation of Ito,f in the absence and presence of NS5806 (10 μM) using the conditioning pre-pulse protocol 
(inset); the data were fitted to Boltzmann equation (n = 25). F, Ito,f recovery from steady-state inactivation recorded using a double-pulse protocol 
with variable inter-pulse intervals (inset) in the absence and presence of NS5806 (n = 25, N = 5) 
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that NS5806 significantly suppressed Ito conducted by Kv4 
family channels through accelerating current inactivation in 
hiPSC-CMs.
Given the striking difference between the effects of 
NS5806 in canine cardiomyocytes14,15 and murine and 
human cardiomyocytes (present study), we tested the effect 
of NS5806 on the Ito in canine cardiomyocytes to confirm 
its potentiating effect under our experimental conditions. 
Indeed, the Ito amplitude was enhanced and the current inacti-
vation was delayed in the presence of 10 μM NS5806 (Figure 
S3), which concurs with the previous reports.
3.3 | Effect of NS5806 on the cloned Kv4 
channels in heterologous expression system
To explore the molecular mechanism(s) underlying strikingly 
different effects of NS5806 on the cardiac Ito in different spe-
cies, we next tested the effect of the compound on cloned 
Kv4.3 channel complex by transiently co-expressing the pore-
forming α-subunit with auxiliary subunits KChIP2 and DPP6 
at different stoichiometry in HEK293 cells. At least two DPP6 
isoforms have been reported: DPP6-L (long) and DPP6-S 
(short). These isoforms differ in the sequence and length of 
the cytoplasmic N-terminal domain but share an identical 
transmembrane domain and a long C-terminal extracellular 
domain.26 Two isoforms have qualitatively similar regulatory 
effects on Kv4.2 channels.27 DPP6-S has been used to test the 
effect of NS5806 on recombinant channel complexes in previ-
ous reports, which have demonstrated that NS5806 enhances 
the current amplitude and concomitantly slows the inactiva-
tion kinetics of Kv4.3/KChIP2/DPP6-S12 or Kv4.2/DPP6-S 
associated with either KChIP2, KChIP3, or KChIP4 channel 
complexes.28 A similar response was observed in this study 
when the DPP6-S was co-expressed with Kv4.3 and KChIP2 
(Figure S4). While consistent with previous observations, 
this recombinant Kv4.3/KChIP2/DPP6-S complex did not re-
capitulate the response to NS5806 of native Ito from mouse 
cardiomyocytes or hiPSC-CMs. To test whether different 
isoforms of DPP6 confer differential responses to NS5806, 
the DPP6-L was co-transfected with Kv4.3 and KChIP2 in 
HEK293 cells. As shown in Figure 4A (left panels), the dif-
ferent instantaneous inactivation kinetics were observed when 
pore-forming subunit Kv4.3 was co-assembled with auxiliary 
subunits KChIP2 or DPP6-L at different expression ratios. 
Evidently, DPP6-L accelerated the current inactivation while 
F I G U R E  3  Effects of NS5806 on Ito in human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). A, Representative 
western blot analysis of Kv4.3 and Kv1.4 in hiPSC-CMs. B, Summary data for Kv4.3 and Kv1.4 western blot densitometry normalized to GAPDH 
(N = 3). C, Representative recordings of Ito before and after NS5806 (10 μM) using protocol shown in the inset. D, I–V relationships of Ito 
currents recorded as in C before and after NS5806 (n = 12, *P < .05, **P < .01, ***P < .001 vs control). E, Concentration-dependent inhibition 
of Ito by NS5806. Data were fitted with a Hill equation; IC50 = 8.3 μM. The number above each data point represents the number of cells at each 
concentration. Representative Ito traces for each concentration are shown in the inset. F, Time constants (τ) of the current inactivation in the absence 
and presence of NS5806. Data were obtained by fitting current traces to a single exponential equation (n = 12, *P < .05, **P < .01 vs control). G, 
Steady-state inactivation of Ito in the absence and presence of NS5806 recorded using the protocol shown in the inset; data were fitted to Boltzmann 
equations (n = 12). H, Summary data for Ito recovery from inactivation in the absence and presence of NS5806 (n = 12) 
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KChIP2 slowed inactivation. These findings were consistent 
with the previous reports.10,11 Representative current traces 
at +40 mV in the absence and presence of NS5806 (10 μM) 
are shown in Figure 4A (right panels). NS5806 had no effect 
on the current amplitude of IKv4.3 and IKv4.3/DPP6-L, but it en-
hanced the peak current of IKv4.3/KChIP2 at test voltages positive 
to +10 mV (Figure 4A; Table S1). Intriguingly, NS5806 sig-
nificantly decreased the peak current of IKv4.3/KChIP2/DPP6-L, and 
the effect was more prominent when the expression of DPP6-L 
was increased by changing Kv4.3/KChIP2/DPP6-L transfec-
tion plasmid ratio from 1:1:1 to 1:1:3 (Figure 4B; Table S2). 
These results clearly demonstrated that NS5806 significantly 
enhanced the current amplitude of Kv4.3/KChIP2 channels 
while inhibiting the current of Kv4.3/KChIP2/DPP6-L chan-
nels. Interestingly, Kv4.3/DPP6-L channels were unaffected 
by NS5806, suggesting that an interplay between KChIP2 and 
DPP6-L is necessary to confer the inhibition.
Similarly, complex effects of NS5806 on the inactiva-
tion kinetics of the cloned channels with the different sub-
unit stoichiometry were observed. As shown in Figure 4C, 
NS5806 did not affect inactivation time constants of IKv4.3 
or IKv4.3/DPP6-L, but it significantly delayed the inactivation 
F I G U R E  4  Effects of NS5806 on cloned Kv4.3/KChIP2/DPP6-L channels in HEK293 cells. A, Representative current traces elicited by 
the depolarizing voltage steps from −40 to +40 mV for 2 seconds from a holding potential of −80 mV at different transfection ratios of Kv4.3: 
KChIP2: DPP6-L (Left). The superimposed current traces at +40 mV in the absence and presence of NS5806 are shown on the right. B, Effect of 
10 μM NS5806 on the peak current of the Kv4.3/KChIP2/DPP6-L currents produced by different subunit transfection ratios, measured at +40 mV. 
C, The time constant of inactivation (τ) of Kv4.3/KChIP2/DPP6-L currents produced by different subunit transfection ratios (n = 22). D, I–V 
relationships of Kv4.3/KChIP2/DPP6-L peak current density at plasmid ratio 1:1:1 before and after 10 μM NS5806 (n = 18, *P < .05, **P < .01 
vs control). E, Steady-state inactivation curves for Kv4.3/KChIP2/DPP6-L channel complex at plasmid ratio 1:1:1 before and after 10 μM NS5806 
(n = 18). F, Recovery from inactivation curves for Kv4.3/KChIP2/DPP6-L channel complex at plasmid ratio1:1:1 before and after 10 μM NS5806 
(n = 18) 
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kinetics of IKv4.3/KChIP2. In contrast, NS5806 accelerated 
the current inactivation in the presence of DPP6-L sub-
units and the effect was stronger at the 1:1:3 plasmid ratio 
of Kv4.3/KChIP2/DPP6-L, as compared to that at 1:1:1 
ratio. NS5806 produced a very similar pattern of effects 
on Kv4.2/KChIP2/DPP6-L channels (Figure S5 and Table 
S3). Taken together, our data suggest that DPP6-L/KChIP2 
levels control the modality of Kv4 channel response to 
NS5806.
To further test whether the effect of NS5806 in the het-
erologous system can be closely matched to that in the na-
tive cardiomyocytes, we further analyzed its actions on the 
cloned Kv4.3/KChIP2/DPP6-L channels at 1:1:1 transfection 
ratio. These experiments revealed that NS5806 significantly 
inhibited the currents elicited by voltages positive to −10 mV 
(Figure 4D). The steady-state inactivation was left-shifted 
with a change of V1/2 from −28.8 ± 0.4 to −42.5 ± 0.2 mV 
(Figure 4E), and the recovery from inactivation was accel-
erated from 30.9 ± 5.1 to 14.4 ± 2.7 ms in the presence of 
NS5806 (Figure 4F).
3.4 | The role of DPP6 in the inhibitory 
action of NS5806 on native Ito
To gain better understanding of the role of DPP6 in the 
pharmacological responses of Kv4 channels, we determined 
the protein abundance of DPP6 in ventricular myocardium 
of dog and mouse, as well as in human hiPSC-CMs. An 
antibody that binds with both DPP6-L and DPP6-S was 
used. The brain tissue was used as a positive control for the 
western blots since both DPP6-L and DPP6-S are present in 
the brain.11,27 As shown in Figure 5A1, two protein bands 
were detected in the brain, the smaller molecule was more 
abundant than the larger one. This finding is consistent with 
higher abundance of DPP6-S, as compared to DPP6-L, in the 
brain.29 Thus, we assumed that two bands seen in our west-
ern blot experiments correspond to DPP6-S and DPP6-L, 
respectively. Intriguingly, a different expression pattern of 
DPP6 isoforms was found among the species tested. Thus, 
DPP6-L was dominantly expressed in both mouse ventricu-
lar myocardium and hiPSC-CMs, while it was almost un-
detectable in canine ventricular myocardium (Figure 5A1). 
In addition, DPP6-S was virtually undetectable in canine 
heart preparation (Figure 5A1). Specificity of the DPP6 an-
tibody was tested by western blot after pre-incubation with 
the blocking antigen, which eliminated both bands in brain 
and heart preparations (Figure 5A2). Notably, the expres-
sion level of KChIP2 protein was comparable among these 
species (Figure S6). Based on the above results we hypoth-
esized that the dominant expression of DPP6-L might be 
responsible for the inhibitory effect of NS5806 on native Ito 
in mouse cardiomyocytes and hiPSC-CMs.
To test this hypothesis, we knocked down DPP6 expres-
sion in hiPSC-CMs using a small interference RNA ap-
proach (the siRNA we used recognized both DPP6-L and 
DPP6-S mRNAs but since DPP6-L is the predominant iso-
form in hiPSC-CMs, we assume that the main effect of the 
knockdown would be mediated by the downregulation of 
DPP6-L). The validity of siRNA DPP6 (SiDPP6) was con-
firmed by RT-PCR (Figure 5B1) and western blot (Figure 
5B2), in which scramble siRNA (SiNC) was used as a con-
trol. After the knock down of DPP6 in hiPSC-CMs, the Ito 
displayed significantly slower inactivation kinetics, further 
evidencing a successful knockdown of DPP6 expression 
(Figure 5B3). Knockdown of DPP6 significantly reduced 
the response to NS5806, albeit the compound still produced 
a modest suppression of the current in hiPSC-CMs (Figure 
5C1,C2). Similarly, NS5806-induced acceleration of the 
current inactivation was antagonized by DPP6 knockdown 
(Figure 5C3). These data provide further evidence that 
DPP6 subunits play a key role in the inhibitory action of 
NS5806 on native Ito.
3.5 | Analysis on the association between 
KChIP2 and DPP6
Although our findings revealed the key role of DPP6 subunits 
in defining pharmacological profile of Ito, the fact that NS5806 
failed to affect the current amplitude and inactivation kinetics 
in Kv4 and Kv4/DPP6 channels suggests that KChIP2 is also 
required for the modulatory effects of NS5806. Specifically, 
both DPP6 and KChIP2 are required for NS5806-mediated 
channel inhibition, while KChIP2 alone confers channel po-
tentiation by NS5806. We further hypothesized that the in-
hibitory effect of NS5806 on the Kv4 channel may depend on 
the association between DPP6-L and KChIP2.
To identify the possible sites involved in association 
between two proteins, the structural models of KChIP2 
and DPP6-L were generated. Based on a known structure 
of KChIP4a,23 a homology model of KChIP2 was gener-
ated (Figure 6A1). The structure of intracellular domain of 
DPP6-L (DPP6-Lin) was predicted using ab initio protein 
prediction approach (Figure 6A2). Top-ranked models of 
both proteins are shown in Figure 6A3. Then, molecular 
docking simulations were performed to identify possible 
binding sites between these two proteins. Ten models were 
generated in total and the model with the most favorable 
binding energy (Figure 6A4) was used as a template for 
site-directed mutagenesis study. The detailed predicted 
results of interactions between DPP6-Lin and KChIP2 in 
the model are shown in Table S4. Residues R7, P33, D36, 
G38, and L44 within the putative KChIP2-associating site 
of DPP6-L (Figure 6B1) and were mutated to alanines 
with an aim to generate a DPP6-L mutant with reduced 
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KChIP2-binding affinity (DPP6-L-Mut). The current for 
Kv4.3/KChIP2/DPP6-L-WT and Kv4.3/KChIP2/DPP6-
L-Mut (1:1:1) channels were then recorded and compared 
(Figure 6B2). The current inactivation kinetics of Kv4.3/
KChIP2/DPP6-L-Mut was significantly slower, as com-
pared to Kv4.3/KChIP2/DPP6-L-WT (Figure 6B3). The 
representative current traces of Kv4.3/KChIP2/DPP6-
L-WT channels and Kv4.3/KChIP2/DPP6-L-Mut chan-
nels in the absence and presence of NS5806 are shown in 
Figure 6C1. Strikingly, the mutations conferred a reversal 
of the effect of NS5806 on the current amplitude: from in-
hibition of IKv4.2/KChIP2/DPP6-L-WT to modest (but significant) 
enhancement of IKv4.2/KChIP2/DPP6-L-Mut (Figure 6C2). In ad-
dition, mutations within the putative KChIP2 interaction 
sites also reversed the effect of NS5806 on the current inac-
tivation kinetics (Figure 6C3). These experiments add fur-
ther support to the hypothesis that an association between 
DPP6 and KChIP2 confers the inhibitory effect of NS5806 
on Kv4 channel.
4 |  DISCUSSION
4.1 | NS5806 suppressed Kv4-generated Ito 
in mouse cardiomyocytes and hiPSC-CMs
NS5806 has been put forward as a prototypic activator of 
Ito.12,13 Yet, the efficacy of the Ito enhancement by NS5806 
F I G U R E  5  DPP6 expression in mouse, canine ventricular tissue, and hiPSC-CMs. A1, Representative immunoblots of DPP6 protein 
expression in mouse left ventricle, canine left ventricle, and hiPSC-CMs. A2, Test for antibody specificity by preincubation with the antigen 
peptide. B1, Efficiency of siRNA-mediated DPP6 knockdown (SiDPP6) in hiPSC-CMs quantified by RT-PCR and compared to non-targeting 
control siRNA (SiNC) (N = 3). B2, Representative immunoblots of DPP6 in hiPSC-CMs treated with siRNA targeting DPP6 (N = 3). B3, Time 
constants (τ) of the current inactivation in hiPSC-CMs treated with siRNA targeting DPP6 and a non-targeting control. Data obtained by fitting 
a single exponential equation (n = 9, *P < .05, **P < .01 vs SiNC). C1, Representative Ito current traces recorded from the hiPSC-CMs treated 
with SiNC or SiDPP6. C2, Effect of siRNA knockdown of DPP6 on the I–V relationships of Ito and on the efficacy of NS5806-mediated current 
inhibition in hiPSC-CMs (left). Summary of the inhibitory effect of 10 μM NS5806 on Ito in SiNC- or SiDPP6-treated hiPSC-CMs is shown on 
the right (n = 10, **P < .01). C3, Effect of DPP6 knockdown on the kinetics of Ito inactivation in the presence of 10 μM NS5806 in hiPSC-CMs 
(*P < .05, **P < .01 vs SiNC) 
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varies significantly between the tissue types and even within 
different regions across the ventricular wall (ie, between 
epicardial, midmyocardial, or endocardial cells15,30). The 
potentiating effects have also been demonstrated on heter-
ologously expressed Kv4.3/Kv4.2 channels in the presence 
of KChIP2 with or without DPP6. In addition, NS5806 
was shown to strongly inhibit cloned Kv1 family channels 
(Kv1.4/Kv1.5).12 A recent study has revealed that NS5806 
markedly increased Ito amplitude in rabbit ventricular myo-
cytes, but it inhibited Ito in rabbit atrial cells.31 These differ-
ent responses are difficult to explain solely by contribution 
of Kv1.4 since Kv4.3, 4.2, and 1.4 are all expressed across 
the rabbit atria.31
Consistent with the previous finding, we observed 
a significant increase in Ito amplitude in the presence of 
NS5806 in canine ventricular myocytes. However, the ef-
fect of NS5806 on native Ito in mouse ventricular cardio-
myocytes as well as in hiPSC-CMs was strikingly different 
as current inhibition was seen instead. In mouse ventricles, 
Kv4.2/Kv4.3 subunits conduct Ito,f, whereas Kv1.4 forms 
Ito,s channels.32 Using specific Kv4 channel blocker com-
bined with kinetic differentiation, our experiments further 
confirmed that Ito,f was specifically inhibited by NS5806 
in mouse ventricular myocytes and hiPSC-CMs. In both 
these cell types, NS5806 significantly accelerated current 
inactivation and shifted voltage dependence of steady-state 
F I G U R E  6  Analysis on the putative interactions between KChIP2 and DPP6-L. A1, Modeling and docking simulation of putative interactions 
between DPP6-Lin and KChIP2. Homology model of KChIP2. A2, The top-ranked model of the intracellular domain of DPP6-L (DPP6-Lin). A3, 
Top-ranked models of both proteins. A4, Best scored model of docking KChIP2 with DPP6-Lin; putative-interacting residues are indicated. B1, 
Schematic depiction of DPP6-L and the location of mutated residues within the putative KChIP2 interaction site. B2, Representative recordings 
of Kv4.3/KChIP2/DPP6-L-WT and Kv4.3/KChIP2/DPP6-L-Mut currents from HEK293 cells using 500 ms square voltage pulses (from −40 to 
+40 mV; holding potential is −80 mV). B3, The time constants of inactivation (τ) of Kv4.3/KChIP2/DPP6-L-WT and Kv4.3/KChIP2/DPP6-L-Mut 
current traces plotted against voltage (**P < .01). C1, Representative recordings of IKv4.3/KChIP2/DPP6-L-WT and IKv4.3/KChIP2/DPP6-L-Mut in HEK293 cells 
before and after 10 μM NS5806. C2, Summary data for the effect of NS5806 on the current amplitudes of Kv4.3/KChIP2/DPP6-L-WT and Kv4.3/
KChIP2/DPP6-L-Mut channels (*P < .05). C3, Summary data for the effect of NS5806 on the current inactivation kinetics (at +40 mV) of Kv4.3/
KChIP2/DPP6-L-WT and Kv4.3/KChIP2/DPP6-L-Mut channels (**P < .01) 
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inactivation to more negative potentials. These effects on 
channel gating could account for the decrease in current 
amplitude.
Consistent with these results, a previous report has 
shown that NS5806 at 10 μM fails to enhance, but rather pro-
duced a small reduction of Ito amplitude in hiPSC-CMs.17 
Our western blot analysis provided further evidence for a 
dominant expression of Kv4 in hiPSC-CMs, while only a 
trace amount of Kv1.4 was found in these cells. This ob-
servation is seemingly at odds with the previous study17 
showing presence of Kv1.4 mRNA in hiPSC-CM; however, 
the abundance of Kv1.4 protein in hiPSC-CM was not in-
vestigated in that study. The different expression pattern 
of ion channels may depend on different maturation state 
of hiPSC-CMs. Yet, variable presence of Kv1.4 brings 
further complexity to Ito modulation by NS5806 since an 
inhibitory effect of NS5806 on cloned Kv1.4 channel has 
been demonstrated.12 Nevertheless, the fact that there were 
comparable levels of Kv1.4 protein abundance in mouse 
and canine ventricular tissue (while the effects of NS5806 
on Ito were opposite) suggests that the effect of NS5806 on 
the Kv4 channel complex is a dominant mechanism of the 
Ito modulation in the heart.
4.2 | DPP6 and KChIP2 subunits confer the 
modality of Ito channel response to NS5806
We think that involvement of different auxiliary subunits 
could offer an explanation for the difference in NS5806 
action in cardiac cells from different species. The KChIP2 
and DPP6 are most likely candidates for auxiliary subunits 
of Kv4-containing Ito channel complex.9 We thus tested the 
effect of NS5806 on cloned Kv4 with KChIP2 and DPP6 
subunits in HEK293 cells. In agreement with the previous 
reports,12 our results indicate that NS5806 significantly en-
hanced the current amplitude of Kv4.3/KChIP2 and Kv4.3/
KChIP2/DPP6-S channels, and concomitantly slowed the 
inactivation kinetics of these channel complexes. On the 
contrary, NS5806 markedly decreased the peak amplitudes 
of currents mediated by Kv4.3/KChIP2/DPP6-L or Kv4.2/
KChIP2/DPP6-L channel complexes and significantly 
sped the inactivation of these channels. The above effect of 
NS5806 was further potentiated when DPP6-L expression 
level was elevated. These changes recapitulated the effect 
of NS5806 on native Ito in the mouse ventricular cells. The 
results suggest that auxiliary subunits DPP6-L and KChIP2 
confer the opposite responses to NS5806. Yet, KChIP2 was 
also necessary for the inhibitory action of NS5806 on Ito 
as Kv4/DPP6-L complex was insensitive to the compound 
(Figure 4A,B).
Consistent with the findings from heterologous expres-
sion system, our western blot analysis demonstrated that 
DPP6-L was dominantly expressed in both mouse ventricu-
lar myocardium and iPSC-CMs. In contrast, in canine ven-
tricular myocardium, DPP6-L presence was undetectable 
while low levels of DPP6-S expression were seen. Levels 
of KChIP2 expression were comparable between all three 
species (Figure 5A). Furthermore, siRNA knockdown of 
DPP6 significantly antagonized the NS5806-induced re-
duction of current amplitude and acceleration of inacti-
vation of native Ito in hiPSC-CMs. Thus, our data clearly 
demonstrate that the inhibitory response to NS5806 in car-
diomyocytes depends on the DPP6-L subunit. The effects 
of NS5806 on cloned Kv4 channel complexes and native 
Ito reported here and in previous reports are summarized 
in Table 1.
4.3 | Possible molecular mechanism 
underlying the inhibitory response to NS5806
Previous study suggested that the potentiating effect of 
NS5806 on Kv4 channels depends on the accessory pro-
tein KChIP2.12 KChIP2 is a cytosolic protein that inter-
acts with the intracellular N-termini of Kv4 subunits33 
and results in a slower inactivation kinetics and accelera-
tion of recovery from inactivation.10 A recent study has 
shown that NS5806 binds to hydrophobic residues on the 
C-terminus of KChIP3 and increases the affinity between 
KChIP3 and the N-terminus of Kv4.3.13 It is likely that the 
similar mechanism underlies the effect of NS5806 on Kv4/
KChIP2 complex channel since KChIP2 and KChIP3 have 
nearly identical NS5806-binding sites. However, how does 
DPP6-L confer the inhibitory effect of NS5806 on Kv4/
KChIP2/DPP6-L channel complex? The DPP6 is a single 
T A B L E  1  Summary for the effects of NS5806 on cloned Kv4 
channel complexes and native Ito channels
Note: Highlighted in blue color are data from the present study; others from 
previous reports (which have been cited in text).
a— No significant effect;↓ Decrease peak current, ↑increase peak current. 
b accelerate inactivation, slow inactivation. 
I
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transmembrane subunit consisting of a short intracellular 
N-terminal domain and a long extracellular C-terminal do-
main.8 When co-expressed with Kv4 subunits, DPP6 (ei-
ther long or short isoform) increases the rate of inactivation 
of a resulting channel complex, negatively shifts the volt-
age dependence of steady-state inactivation, and increases 
the rate of recovery from inactivation.11 Interestingly, the 
present study revealed that NS5806 produces biophysically 
very similar effects on both native Ito channels in tissues 
expressing DPP6-L (murine and human but not canine) 
and on recombinant Kv4/KChIP2/DPP6-L channel com-
plexes. It is thought that the discrete and specific interac-
tions mediate the effects of KChIP and DPP subunits on 
the gating of Kv4 channels.34 Thus, we speculate that the 
inhibitory effect of NS5806 on the Ito current might result 
from the increased binding affinity between DPP6-L and 
the Kv4/KChIP2 complex. One explanation for the ob-
served effects might be in that (a) intracellular N-terminal 
domain of DPP6-L interacts with KChIP2, (b) the associa-
tion between two subunits exposes NS5806-binding site in 
DPP6-L while hindering the binding of NS5806 to KChIP2 
subunits. In support of this scenario, the molecular dock-
ing simulations indicated that several putative residues, 
including R7, P33, D36, G38, and L44 in the N-terminus 
of DPP6-L, are likely to associate with the C-terminus of 
KChIP2. Mutation of these residues reversed the inhibi-
tory effect of NS5806 into potentiation of the Ito current. 
In addition, the acceleration of inactivation was turned 
into slowing down. Interestingly, according to the docking 
simulation, the putative KChIP2-DPP6-L association site 
is predominantly localized in the C-terminus of KChIP2, 
which has been reported to contain also the binding site 
for NS5806.13 This may be the reason why the association 
between two subunits could hamper binding of NS5806 to 
KChIP2 and promote binding to DPP6-L instead. Binding 
of NS5806 to DPP6-L might facilitate its association with 
the pore-forming Kv4 subunit and “switch” the potentia-
tion of Ito into inhibition. Interestingly, previous studies 
reported that the peak amplitudes of currents mediated by 
ternary Kv4/KChIP2/DPP6-S channel complexes were po-
tentiated and the current inactivation significantly slowed 
by NS5806.12,28 DPP6–S isoform lacks 62 N-terminal resi-
dues that form putative KChIP-interacting site. Hence, the 
ability of DPP6-S to associate with KChIP2 is likely to be 
compromised. This is a likely explanation for the divergent 
results observed with the DPP6-S and DPP6-L isoforms. 
Indeed, our data predict that similarly to the DPP6-L-Mut 
(Figure 6), the DPP6-S isoform would not be able to bind 
to KChIP2 and, thus, to switch the modality of NS5806 
response of the Ito channel complex. However, further 
structural insights are needed to confirm the direct inter-
action between KChIP2 and DPP6-L. In addition, KCNE 
β-subunits also regulate Kv4 channels in the hearts of some 
species and may influence the response to channel modula-
tor.35 Further studies are needed to test the possibility of the 
involvement of KCNE subunits in the NS5806 response.
5 |  CONCLUSION
This study discovers molecular mechanism for the oppos-
ing response of cardiac Kv4 channel complex to its modula-
tor NS5806. We show that the alternative assembly of the 
complex with different auxiliary subunits in different species 
results in channels with strikingly different biophysical and 
pharmacological properties. These findings provide novel in-
sight for the development of new ion channel modulators for 
treatment of cardiovascular diseases.
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